Oncomatryx Biopharma

Derio, Spain · Founded 2009 · Privately Held (backing)

Developer of stroma-targeted precision drugs and diagnostics intended to fight against invasive tumours. Oncomatryx Biopharma is based in Derio, Spain and was founded in 2009. Its last reported valuation was $112 million in Mar 2022. It has raised $146 million.

Last reported valuation

$111.8M

Oct 2026

Priced at

—

Total raised

$146.0M

Last round

—

How much has Oncomatryx Biopharma raised?

$146.0Macross 0 recorded rounds

Free account

More of Oncomatryx Biopharma with a free account

·Watch Oncomatryx Biopharma: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Oncomatryx Biopharma investors

9 investors are on record for Oncomatryx Biopharma, including European Innovation Council, INNVIERTE SICC, Basque Government and Bilbao Bizkaia Kutxa.

For fundraisers

Raising for a company like Oncomatryx Biopharma?

9 investors have backed Oncomatryx Biopharma.

See all 9 investors →

Frequently asked about Oncomatryx Biopharma

How much has Oncomatryx Biopharma raised?: Oncomatryx Biopharma has raised $146.0M in total across 0 recorded funding rounds.